Literature DB >> 22328681

High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women.

Anna K Hedström1, Tomas Olsson, Lars Alfredsson.   

Abstract

In a Swedish population-based case-control study (1571 cases, 3371 controls), subjects with different body mass indices (BMIs) were compared regarding multiple sclerosis (MS) risk, by calculating odds ratios (OR) with 95% confidence intervals (95% CI). Subjects whose BMI exceeded 27 kg/m(2) at age 20 had a two-fold increased risk of developing MS compared with normal weight subjects. Speculatively, the obesity epidemic may explain part of the increasing MS incidence as recorded in some countries. Measures taken against adolescent obesity may thus be a preventive strategy against MS.

Entities:  

Mesh:

Year:  2012        PMID: 22328681     DOI: 10.1177/1352458512436596

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  91 in total

1.  Effect of aerobic interval training on serum IL-10, TNFα, and adipokines levels in women with multiple sclerosis: possible relations with fatigue and quality of life.

Authors:  Motahare Mokhtarzade; Rouholah Ranjbar; Nastaran Majdinasab; Darpan Patel; Mehdieh Molanouri Shamsi
Journal:  Endocrine       Date:  2017-06-14       Impact factor: 3.633

2.  Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors.

Authors:  Milena A Gianfrancesco; Brigid Acuna; Ling Shen; Farren B S Briggs; Hong Quach; Kalliope H Bellesis; Allan Bernstein; Anna K Hedstrom; Ingrid Kockum; Lars Alfredsson; Tomas Olsson; Catherine Schaefer; Lisa F Barcellos
Journal:  Obes Res Clin Pract       Date:  2014-03-06       Impact factor: 2.288

3.  Improved prediction of HIT in the SICU using an improved model of the Warkentin 4-T system: 3-T.

Authors:  Matthew B Bloom; Jeffrey Johnson; Oksana Volod; Ernest Y Lee; Terris White; Daniel R Margulies
Journal:  Am J Surg       Date:  2019-07-29       Impact factor: 2.565

Review 4.  Dietary Interventions and Multiple Sclerosis.

Authors:  Ghadah Altowaijri; Allison Fryman; Vijayshree Yadav
Journal:  Curr Neurol Neurosci Rep       Date:  2017-03       Impact factor: 5.081

Review 5.  The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.

Authors:  John Grizzanti; Hyoung-Gon Lee; Antoni Camins; Merce Pallas; Gemma Casadesus
Journal:  Nutr Res       Date:  2016-11-08       Impact factor: 3.315

Review 6.  Multiple sclerosis.

Authors:  Massimo Filippi; Amit Bar-Or; Fredrik Piehl; Paolo Preziosa; Alessandra Solari; Sandra Vukusic; Maria A Rocca
Journal:  Nat Rev Dis Primers       Date:  2018-11-08       Impact factor: 52.329

Review 7.  Gut-brain communication in demyelinating disorders.

Authors:  Sami Sauma; Patrizia Casaccia
Journal:  Curr Opin Neurobiol       Date:  2020-02-15       Impact factor: 6.627

8.  Diet quality and risk of multiple sclerosis in two cohorts of US women.

Authors:  Dalia L Rotstein; Marianna Cortese; Teresa T Fung; Tanuja Chitnis; Alberto Ascherio; Kassandra L Munger
Journal:  Mult Scler       Date:  2018-10-23       Impact factor: 6.312

Review 9.  Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.

Authors:  J Nicholas Brenton; Brenda L Banwell
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

10.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.